Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Rare Disease Group, |
RCV000754947 | SCV000788372 | uncertain significance | Jeune thoracic dystrophy | 2018-05-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000754947 | SCV002170286 | pathogenic | Jeune thoracic dystrophy | 2024-10-30 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 209 of the DYNC2H1 protein (p.Phe209Ile). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This missense change has been observed in individual(s) with asphyxiating thoracic dystrophy and/or short-rib polydactyly syndrome (PMID: 19361615, 29068549). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 6509). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000006882 | SCV005678260 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-05-30 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000006882 | SCV000027078 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2009-04-01 | no assertion criteria provided | literature only |